Bind Therapeutics is categorized under Noncommercial Biotechnical Research in Cambridge, MA and active since 2006.
Bind Therapeutics was established in 2006, and today employs 1 to 4, earning $5.000.000 to $9.999.999 per year. This is a Noncommercial Biotechnical Research business, which does work in the B2B market, and is classified as a Noncommercial Biotechnical Research, under code number 4461100 by the NAICS.
If you are seeking more information, feel free to contact Scott Minick, Chief Executive Officer at the company’s single location by writing to 325 Vassar St, Cambridge, Massachusetts MA 02139 or by phoning (617) 491-3400. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Bind Therapeutics |
| Contact Person: | Scott Minick, Chief Executive Officer |
| Address: | 325 Vassar St, Cambridge, Massachusetts 02139 |
| Phone Number: | (617) 491-3400 |
| Website Address: | bindtherapeutics.com |
| Annual Revenue (USD): | $5.000.000 to $9.999.999 |
| Founded: | 2006 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Noncommercial Biotechnical Research |
| SIC Code: | 8733 |
| NAICS Code: | 4461100 |
| Share This Business: |
Bind Therapeutics was started in 2006 to provide professional Noncommercial Biotechnical Research under the SIC code 8733 and NAICS code 4461100. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $5.000.000 to $9.999.999 per annum.
Feel free to contact Scott Minick, Chief Executive Officer for inquiries that concern Bind Therapeutics by calling the company number (617) 491-3400, as your correspondence is most welcome. Additionally, the physical location of the single location of Bind Therapeutics can be found at the coordinates 42.35488,-71.1056 as well as the street address 325 Vassar St in Cambridge, Massachusetts 02139.
For its online presence, you may visit Bind Therapeutics’s website at bindtherapeutics.com and engage with its social media outlets through on Twitter and on Facebook.